The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of ...
Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with ...
Researchers at Memorial Sloan Kettering and University Hospital in Würzburg, Germany, have identified a simple way to temporarily switch off CAR T cells with a commonly used drug. The approach could ...
A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...
In an interview on treatments following failure of chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma, Rahul Banerjee, MD outlines the theory behind potential therapeutic strategies ...
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid ...
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can block T cells—the killer cells of the immune system—in the ...
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results